NITRIC OXIDE-ASSOCIATED VASORELAXING EFFECT OF AN ANTIULCER AGENT, BENEXATE HYDROCHLORIDE BETADEX
NITRIC OXIDE-ASSOCIATED VASORELAXING EFFECT OF AN ANTIULCER AGENT, BENEXATE HYDROCHLORIDE BETADEX
复制标题
DOI:
10.1002/ddr.430360103
复制
发表时间:
1995-09-01
影响因子:
3.8
通讯作者:
MATSUNAGA, K
中科院分区:
文献类型:
--
作者:
IWASAKI, T;MATSUNAGA, K
The vasorelaxing effect of benexate hydrochloride betadex (BHB) was examined in rat thoracic aortic ring with and without endothelium. BHB at 1 similar to 100 mu M caused concentration-dependent vasorelaxation in both endothelium-intact and -denuded aortas precontracted with phenylephrine (1 mu M), with its relaxing effect being significantly more potent in the endothelium-intact aorta. This partial endothelium-dependent vasorelaxation by BHB was significantly inhibited by N-omega-nitro-L-arginine methylester (100 mu M), an inhibitor of nitric oxide (NO) synthase, and hemoglobin (10 mu M), an NO scavenger, but not by indomethacin (5 mu M), an inhibitor of cyclooxygenase. The content of c-GMP, a second messenger of NO, in endothelium-intact aorta treated with BHB (30 mu M) significantly increased by about twofold of the control level. NO synthase (NOS) activity by the treatment of BHB at 100 mu M increased to about the same level by the treatment of L-arginine at 10 mu M. Taken together, these results suggest that the vasorelaxing effect of BHB is, in part, associated with NO synthesis and release from the endothelium but not with the prostaglandin system. The mechanism of NO synthesis and release from the endothelium by BHB might be NOS activation by the effect as a substrate of NOS. (C) 1995 Wiley-Liss, Inc.